RELEVANCE OF THROMBIN-ANTITHROMBIN COMPLEX AND PROTHROMBIN FRAGMENT F1+2 IN PATIENTS UNDERGOING AORTOCORONARY BYPASS-SURGERY

被引：0
|
作者：
PARAMO, JA [1 ]
RIFON, J [1 ]
FERNANDEZ, J [1 ]
CUESTA, B [1 ]
COLLADOS, MT [1 ]
ROCHA, E [1 ]
机构：
[1] UNIV NAVARRA,FAC MED,HEMATOL SERV,PAMPLONA,SPAIN
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [21] Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA
    Yang, Yong
    Feng, Gangning
    Yan, Jiangbo
    Wu, Long
    Wang, Faxuan
    Ding, Dong
    Wang, Hui
    Jin, Qunhua
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [22] Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA
    Yang, Yong
    Feng, Gangning
    Yan, Jiangbo
    Wu, Long
    Wang, Faxuan
    Ding, Dong
    Wang, Hui
    Jin, Qunhua
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [23] PROTHROMBIN FRAGMENT 1+2 (F1+2), DEGRADATION PRODUCTS OF FIBRIN (FBDP), AND THROMBIN-ANTITHROMBIN-III COMPLEX (TAT) INCREASED IN CROHNS-DISEASE (CD)
    KJELDSEN, J
    LASSEN, JF
    DEMUCKADELL, OBS
    GASTROENTEROLOGY, 1995, 108 (04) : A849 - A849
  • [24] Fibrinopeptide A, prothrombin fragment 1+2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol)
    Sorano, GG
    Paoletti, P
    Casciu, G
    Mameli, G
    Marongiu, F
    HAEMOSTASIS, 1997, 27 (03) : 125 - 130
  • [25] Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1+2
    Lambropoulos, AF
    Foka, Z
    Makris, M
    Daly, M
    Kotsis, A
    Makris, PE
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (08) : 485 - 489
  • [26] Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism
    Kyrle, PA
    Stumpflen, A
    Hirschl, M
    Bialonczyk, C
    Herkner, K
    Speiser, W
    Weltermann, A
    Kaider, A
    Pabinger, I
    Lechner, K
    Eichinger, S
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (05) : 1327 - 1331
  • [27] CARDIOPROTECTIVE EFFECTS OF ACADESINE IN PATIENTS WITH UNSTABLE ANGINA UNDERGOING AORTOCORONARY BYPASS-SURGERY
    DEMEYERE, RH
    VANKERREBROECK, CJ
    FLAMENG, WJ
    CIRCULATION, 1994, 90 (04) : 370 - 370
  • [28] PROTHROMBIN FRAGMENT F1+2 PLASMA-CONCENTRATIONS IN PATIENTS WITH GYNECOLOGIC MALIGNANCIES
    HANZAL, E
    TATRA, G
    GYNECOLOGIC ONCOLOGY, 1993, 49 (03) : 373 - 376
  • [29] Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism
    Kyrle, PA
    Eichinger, S
    Pabinger, I
    Stumpflen, A
    Hirschl, M
    Bialonczyk, C
    Schneider, B
    Mannhalter, C
    Melichart, M
    Traxler, G
    Weltermann, A
    Speiser, W
    Lechner, K
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (05) : 829 - 833
  • [30] PREOPERATIVE FIBRINOLYTIC POTENTIAL IN PATIENTS UNDERGOING AORTOCORONARY BYPASS-SURGERY - RELATION TO GRAFT OCCLUSION
    RIFON, J
    PARAMO, JA
    LLORENS, R
    CASARES, J
    FERNANDEZ, J
    ROCHA, E
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1023 - 1023
12345